Protagonist Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.About PTGX
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.
PTGX Key Statistics
Stock Snapshot
As of today, Protagonist Therapeutics(PTGX) shares are valued at $103.80. The company's market cap stands at 6.33B, with a P/E ratio of -48.57.
On 2026-05-06, Protagonist Therapeutics(PTGX) stock moved within a range of $97.45 to $114.94. With shares now at $103.80, the stock is trading +6.5% above its intraday low and -9.7% below the session's peak.
Trading volume for Protagonist Therapeutics(PTGX) stock has reached 397.92K, versus its average volume of 589.19K.
Over the past 52 weeks, Protagonist Therapeutics(PTGX) stock has traded between a high of $114.94 and a low of $41.29.
Over the past 52 weeks, Protagonist Therapeutics(PTGX) stock has traded between a high of $114.94 and a low of $41.29.
Analyst ratings
92%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.